Veterinary medicinal products controlling Varroa destructor parasitosis in bees - Scientific guideline

Concept paper on the revision of the guideline on veterinary medicinal products controlling Varroa destructor parasitosis in bees

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Zercepac, trastuzumab, Date of authorisation: 27/07/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Date of authorisation: 21/09/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Xadago, safinamide, Date of authorisation: 23/02/2015, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Summary of opinion: Rybrevant, 25/07/2024 Positive

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2024